BDSX insider buying and SEC filings, explained
Biodesix Inc. · CIK 1439725
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$3.1M
Insiders who bought
1
Sold (not marked 10b5-1)
$116K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 12, 2026 | Purchase (code P) | Jack W. Schuler (10% owner and Emeritus Director) bought 15,000 shares indirectly (by trust) at about $24.47 ($367K), reported as a purchase (code P). Holdings by trust up 3% to 555,810 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 13, 2026 |
| Aug 10–11, 2026 | Purchase (code P) | Jack W. Schuler (10% owner and Emeritus Director) bought 27,600 shares indirectly (by trust) between Aug 10 and Aug 11 at about $24.13 ($666K), reported as a purchase (code P). Holdings by trust up 5% to 540,810 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 12, 2026 |
| Feb 23, 2026 | Sale | Chris Vazquez (Chief Accounting Officer) sold 211 shares at about $12.78 ($3K). Holdings down 12% to 1,586 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 23, 2026 | Sale | Robin Harper Cowie (CFO) sold 535 shares at about $12.78 ($7K). Holdings down 3% to 16,231 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 23, 2026 | Sale | Scott Hutton (CEO and Director) sold 1,490 shares at about $12.78 ($19K). Holdings down 3% to 48,767 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 23, 2026 | Sale | Gary Anthony Pestano (Chief Development Officer) sold 556 shares at about $12.78 ($7K). Holdings down 5% to 10,359 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 23, 2026 | Sale | Kieran O'Kane (Chief Commercial Officer) sold 535 shares at about $12.78 ($7K). Holdings down 5% to 9,819 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 10, 2026 | Sale | Robin Harper Cowie (CFO) sold 941 shares at about $10.08 ($9K). Holdings down 6% to 15,297 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 10, 2026 | Sale | Chris Vazquez (Chief Accounting Officer) sold 101 shares at about $10.08 ($1K). Holdings down 8% to 1,234 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 10, 2026 | Sale | Kieran O'Kane (Chief Commercial Officer) sold 584 shares at about $10.08 ($6K). Holdings down 6% to 8,885 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 10, 2026 | Sale | Gary Anthony Pestano (Chief Development Officer) sold 540 shares at about $10.08 ($5K). Holdings down 5% to 9,387 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 10, 2026 | Sale | Scott Hutton (CEO and Director) sold 3,559 shares at about $10.08 ($36K). Holdings down 7% to 45,413 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Jan 23–26, 2026 | Purchase (code P) | Jack W. Schuler (10% owner and Emeritus Director) bought 100,000 shares indirectly (by trust) between Jan 23 and Jan 26 at about $11.81 ($1.2M), reported as a purchase (code P). Holdings by trust up 7% to 1,563,210 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 27, 2026 |
| Jan 22, 2026 | Purchase (code P) | Jack W. Schuler (10% owner and Emeritus Director) bought 82,465 shares indirectly (by trust) at about $10.96 ($904K), reported as a purchase (code P). Holdings by trust up 6% to 1,463,210 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 26, 2026 |
| Jan 16, 2026 | Sale | Chris Vazquez (Chief Accounting Officer) sold 83 shares at about $8.15 ($676). Holdings down 7% to 1,072 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 20, 2026 |
| Jan 16, 2026 | Sale | Gary Anthony Pestano (Chief Development Officer) sold 298 shares at about $8.15 ($2K). Holdings down 3% to 8,446 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 20, 2026 |
| Jan 16, 2026 | Sale | Kieran O'Kane (Chief Commercial Officer) sold 298 shares at about $8.15 ($2K). Holdings down 4% to 7,869 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 20, 2026 |
| Jan 16, 2026 | Sale | Scott Hutton (CEO and Director) sold 970 shares at about $8.15 ($8K). Holdings down 2% to 38,974 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 20, 2026 |
| Jan 16, 2026 | Sale | Robin Harper Cowie (CFO) sold 298 shares at about $8.15 ($2K). Holdings down 2% to 13,654 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 20, 2026 |
39 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BDSX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.